| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1210410B1 Metal binding compounds and their use in cell culture medium compositions |
| 01/16/2008 | EP1100534B1 Equine system for non-surgical artificial insemination |
| 01/16/2008 | EP1098961B1 Interferon inducing genetically engineered attenuated viruses |
| 01/16/2008 | EP1074268B1 Preventives or remedies for inflammatory intestinal diseases containing il-6 receptor antagonist antibodies |
| 01/16/2008 | EP0991761B1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107360A HCV F protein and uses thereof |
| 01/16/2008 | CN101107359A A method of prime-boost vaccination |
| 01/16/2008 | CN101107269A Monoclonal antibodies against NKG2A |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101107011A Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics |
| 01/16/2008 | CN101107010A Modified streptococcal polysaccharides and uses thereof |
| 01/16/2008 | CN101107009A Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide |
| 01/16/2008 | CN101107008A Immunogenic composition |
| 01/16/2008 | CN101107007A GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 01/16/2008 | CN101104854A Antihuman telomere enzyme reverse transcriptase single-chain antibody |
| 01/16/2008 | CN101104641A Fusion protein of PRRS virus used as swine procreation and respiratory tract syndrome vaccine |
| 01/16/2008 | CN101104639A Preparation for anti human B7-H3 monoclonal antibody and application thereof |
| 01/16/2008 | CN101104636A HIV peptides from gag p17 and p24 conservative region and its uses in such as vaccine |
| 01/16/2008 | CN101104075A Genetically engineered wine-brewing yeast live vaccine and its preparation method and application |
| 01/16/2008 | CN100362094C Anthrax bacillus strain without pX01 and pX02 plasmid and its use |
| 01/16/2008 | CN100362018C Recombinant monoclonal antibody against EGFR |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/16/2008 | CN100361708C Fusion protein for stimulating organism to produce FMDV antibody and its coding gene and uses |
| 01/16/2008 | CN100361707C Method for treating gastrointestinal damage |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319144 Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7319028 Process for producing sporangia of Bacillus popilliae, control agent, and controlling method |
| 01/15/2008 | US7319012 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity |
| 01/15/2008 | US7319006 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/15/2008 | US7318928 Molecular vaccine linking intercellular spreading protein to an antigen |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | US7318926 Complex of antigen, antibodies or ligand, receptors; therapy, prevention of human diseases |
| 01/15/2008 | US7318924 Antibodies against cancer |
| 01/15/2008 | US7318923 Humanized anti-βantibodies |
| 01/15/2008 | US7318921 Therapeutic compositions that alter the immune response |
| 01/15/2008 | CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/15/2008 | CA2093427C Molecular clones of hiv-1 and uses thereof |
| 01/15/2008 | CA2090549C Bacterial surface protein expression |
| 01/10/2008 | WO2008006118A2 Novel regimens for treating diseases and disorders |
| 01/10/2008 | WO2008006117A2 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/10/2008 | WO2008006106A2 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 01/10/2008 | WO2008006036A2 Conditioned cell immunization |
| 01/10/2008 | WO2008005828A2 PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING ANTIBODY MOLECULES SPECIFIC TO LAMININ-5 α3 CHAIN DOMAINS G1G2 AND USE THEREOF |
| 01/10/2008 | WO2008005556A2 Tat-048 and methods of assessing and treating cancer |
| 01/10/2008 | WO2008005531A2 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | WO2008005469A2 Igfbp2 biomarker |
| 01/10/2008 | WO2008005429A2 Composition for modulating the expression of cell adhesion molecules |
| 01/10/2008 | WO2008005315A2 Automatic injection device |
| 01/10/2008 | WO2008005084A2 Methods to prevent and treat diseases |
| 01/10/2008 | WO2008004760A1 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same |
| 01/10/2008 | WO2008004536A1 Toxin detection method |
| 01/10/2008 | WO2008004247A1 A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections |
| 01/10/2008 | WO2008003748A2 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 01/10/2008 | WO2008003734A1 Combination vaccine against streptococcus |
| 01/10/2008 | WO2008003688A1 Antimicrobial composition and uses thereof |
| 01/10/2008 | WO2008003473A2 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/10/2008 | WO2008003319A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | WO2008003317A1 Prevention of rash in patients undergoing anti-egfr therapy |
| 01/10/2008 | WO2007128987A3 Therapy targeting cathepsin s |
| 01/10/2008 | WO2007128806A3 Methods for the in vitro screening of compounds inhibiting production of infectious hiv-1 virions |
| 01/10/2008 | WO2007121491A8 Hcv vaccinations |
| 01/10/2008 | WO2007109686A3 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 01/10/2008 | WO2007109129A8 Methods for preparing complex multivalent immunogenic conjugates |
| 01/10/2008 | WO2007092640A3 Antibodies that bind par-2 |
| 01/10/2008 | WO2007084353A3 Mycobacterial seca2 mutants |
| 01/10/2008 | WO2007070671A3 Therapeutic methods for inhibiting tumor growth with dll4 antagonists |
| 01/10/2008 | WO2007067514A3 Methods for identifying modulators of hedgehog autoprocessing |
| 01/10/2008 | WO2006131952A8 Novel analgesic treatment with prolonged effect |
| 01/10/2008 | WO2006090750A8 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 01/10/2008 | WO2006044864A3 Vaccine adjuvant |
| 01/10/2008 | WO2005061534A3 Improved tuberculosis vaccines |
| 01/10/2008 | US20080010694 Method of acquiring immunological tolerance |
| 01/10/2008 | US20080009438 Screening methods for compounds useful in the regulation of body weight |
| 01/10/2008 | US20080009031 Mutant cells with altered sialic acid |
| 01/10/2008 | US20080009022 Immunization of dairy cattle with chimeric gapC protein against streptococcus infection |
| 01/10/2008 | US20080009014 Receptor activator of NF-kappaB |
| 01/10/2008 | US20080009008 Composition and method for treating lupus nephritis |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | US20080008726 Vaccine Composition Against Rhodococcus Equi |
| 01/10/2008 | US20080008725 Influenza recombinant subunit vaccine |
| 01/10/2008 | US20080008724 Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/10/2008 | US20080008723 comprising a conserved di-glucosyl -tri-heptosyl inner-core moiety ; Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm); toxoids |
| 01/10/2008 | US20080008722 Lower immunotoxicity and having a high neutralization titer, veterinary medicine |
| 01/10/2008 | US20080008721 Preventive and therapeutic use of polypeptides from African Swine virus as vaccines |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/10/2008 | US20080008719 Methods and compositions for the treatment of prostate cancer |
| 01/10/2008 | US20080008718 Ornithobacterium Rhinotracheale Subunit Vaccines |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008716 Combined Pharmaceutical Composition Comprising an Anti-4-1BB Monoclonal Antibody and Chemotherapeutic Anti-Cancer Agent for Preventing and Treating Cancer Disease |
| 01/10/2008 | US20080008715 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 01/10/2008 | US20080008714 TWEAK receptor agonists as anti-angiogenic agents |